Cetera Investment Advisers’s VanEck Biotech ETF BBH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$386K Sell
2,055
-49
-2% -$9.44K ﹤0.01% 3751
2025
Q4
$398K Sell
2,104
-32
-1% -$5.92K ﹤0.01% 3643
2025
Q3
$354K Buy
2,136
+105
+5% +$17.1K ﹤0.01% 3696
2025
Q2
$311K Sell
2,031
-1,063
-34% -$158K ﹤0.01% 3363
2025
Q1
$487K Buy
3,094
+423
+16% +$68.7K ﹤0.01% 2858
2024
Q4
$419K Buy
2,671
+404
+18% +$68K ﹤0.01% 2816
2024
Q3
$402K Buy
2,267
+72
+3% +$12.8K ﹤0.01% 2837
2024
Q2
$370K Sell
2,195
-3,561
-62% -$582K ﹤0.01% 2839
2024
Q1
$957K Buy
+5,756
New +$953K ﹤0.01% 2104
2023
Q2
Sell
-2,500
Closed -$405K 2204
2023
Q1
$405K Sell
2,500
-70
-3% -$11.3K ﹤0.01% 1542
2022
Q4
$411K Buy
+2,570
New +$407K ﹤0.01% 1482
2022
Q3
Sell
-2,726
Closed -$397K 1738
2022
Q2
$397K Sell
2,726
-2,230
-45% -$332K 0.01% 1240
2022
Q1
$804K Sell
4,956
-1,418
-22% -$230K 0.01% 897
2021
Q4
$1.21M Buy
6,374
+16
+0.3% +$3.08K 0.02% 741
2021
Q3
$1.28M Buy
6,358
+3,596
+130% +$755K 0.02% 687
2021
Q2
$557K Sell
2,762
-710
-20% -$132K 0.01% 1064
2021
Q1
$609K Sell
3,472
-22
-0.6% -$3.98K 0.01% 871
2020
Q4
$593K Buy
+3,494
New +$576K 0.01% 884

Other funds holding BBH

Cetera Investment Advisers's BBH Position: Q1 2026 in Review

Cetera Investment Advisers reduced its VanEck Biotech ETF (BBH) stake by 2.3% in Q1 2026, selling an estimated $9.44K and leaving 2,055 shares worth $386K. The position accounts for ﹤0.01% of the portfolio, ranked #3751.

Cetera Investment Advisers first reported a position in BBH in Q4 2020 and has held it in 18 quarters since. The position peaked at $1.28M in Q3 2021. 112 funds tracked by Wall St. Rank hold BBH as of Q1 2026.

  • Cetera Investment Advisers held 2,055 shares of VanEck Biotech ETF worth $386K as of Q1 2026.
  • Cetera Investment Advisers sold 49 VanEck Biotech ETF shares in Q1 2026, an estimated $9.44K.
  • VanEck Biotech ETF made up ﹤0.01% of Cetera Investment Advisers's portfolio in Q1 2026, its #3751 holding.
  • Cetera Investment Advisers first reported a position in VanEck Biotech ETF in Q4 2020 and has held it in 18 quarters since.
  • Cetera Investment Advisers's VanEck Biotech ETF position peaked at $1.28M in Q3 2021.
  • 112 funds tracked by Wall St. Rank held VanEck Biotech ETF as of Q1 2026.

Based on Cetera Investment Advisers's 13F filing for Q1 2026, filed 13 May 2026.